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Abstract
Background The projection that by 2025, about 75% of cancer cases will be in the developing world is recognised by 
the WHO and the International Atomic Energy Agency. Radiation treatment machines (Cobalt-60 and linear 
accelerators) are critical for curative and palliative care. With an estimated global shortage of 5000 treatment machines, 
even commissioning one per week would require a century to solve the current shortfall. Despite, or possibly because 
of, these alarming statistics, there has been little concerted eﬀ ort to solve the cancer care problem which is believed 
by some to be too expensive and overwhelming. 
Methods The radiation oncology professional community recognises the need for international education. A key 
impetus for addressing the capacity shortage is led by trainees and workers at the start of their careers, including 
in-country rotations. Given the enormity of the need, the not-for-proﬁ t International Cancer Expert Corps was 
established in 2013 to address the need for a sustainable, capable workforce using an innovative multisector, 
mentorship model that included the creation of a career path in altruistic service. The Global Task Force for Radiation 
for Cancer Control of the Union for International Cancer Control demonstrated a potential path forward for building 
radiation therapy capacity that has a positive outcome both economically and medically. The challenge is to engage 
potential stakeholders to establish cancer control programmes, including treatment.
Findings Bringing together ongoing eﬀ orts is critical and best done with formal collaborations between existing 
programmes, allowing for individual recognition and a range of approaches while keeping competition that can 
dissuade investment to a minimum. Partnerships are developing among: early stage career cancer experts committed 
to global health; experts in the private practice sector; organisations interested in supplying refurbished equipment; 
oncologists addressing health disparities among indigenous populations in resource-rich countries; retirees seeking 
opportunities to use their skills to help the underserved; linear accelerator manufacturers; and government agencies 
and foundations working to eliminate dangerous nuclear material, especially in unstable countries. 
Interpretation Stakeholders from sectors not historically engaged in health care are forming unique partnerships 
with common goals and a willingness to address the challenge of global cancer care.
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